litlas
ログインアカウント作成

A. Zink

1996–2024 年に発表

別表記
A Zink
83
論文数
19,112
被引用数
65
h 指数
81
i10 指数

被引用数

A. Zink の年別被引用数1987 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 8 件1998 年: 被引用 4 件1999 年: 被引用 6 件2000 年: 被引用 3 件2001 年: 被引用 5 件2002 年: 被引用 26 件2003 年: 被引用 43 件2004 年: 被引用 60 件2005 年: 被引用 111 件2006 年: 被引用 99 件2007 年: 被引用 104 件2008 年: 被引用 114 件2009 年: 被引用 107 件2010 年: 被引用 135 件2011 年: 被引用 186 件2012 年: 被引用 133 件2013 年: 被引用 143 件2014 年: 被引用 151 件2015 年: 被引用 155 件2016 年: 被引用 110 件2017 年: 被引用 141 件2018 年: 被引用 128 件2019 年: 被引用 547 件2020 年: 被引用 532 件2021 年: 被引用 402 件2022 年: 被引用 323 件2023 年: 被引用 228 件2024 年: 被引用 449 件2025 年: 被引用 136 件2026 年: 被引用 7 件1988〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,229 件、この内訳の 15.5%イギリス: 引用元論文 722 件、この内訳の 9.1%ドイツ: 引用元論文 719 件、この内訳の 9.1%オランダ: 引用元論文 470 件、この内訳の 5.9%イタリア: 引用元論文 425 件、この内訳の 5.4%フランス: 引用元論文 378 件、この内訳の 4.8%カナダ: 引用元論文 362 件、この内訳の 4.6%スペイン: 引用元論文 281 件、この内訳の 3.5%中国: 引用元論文 242 件、この内訳の 3%スイス: 引用元論文 236 件、この内訳の 3%日本: 引用元論文 225 件、この内訳の 2.8%スウェーデン: 引用元論文 202 件、この内訳の 2.5%
0%15.5%その他 30.8%

機関

分野

  • Medicine87%
  • Immunology and Microbiology5.1%
  • Biochemistry, Genetics and Molecular Biology4%
  • Engineering0.9%
  • Health Professions0.7%
  • Neuroscience0.4%
  • その他1.9%

トピック

  • Rheumatoid Arthritis Research and Therapies19.4%
  • Spondyloarthritis Studies and Treatments12.1%
  • Autoimmune and Inflammatory Disorders Research6.3%
  • Systemic Lupus Erythematosus Research4.8%
  • Psoriasis: Treatment and Pathogenesis4.2%
  • Pregnancy and Medication Impact2.2%
  • その他51%

共著者

全論文

検索で開く
  1. EULAR definition of difficult-to-treat rheumatoid arthritis

    著者: György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C. van der Goes, Alison Kent, Margôt Bakkers, Etienne Blaas, Ladislav Šenolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W. G. Jacobs, Rinie Geenen, Hans Bijlsma, A. Zink, Daniel Aletaha, Leonard Schoneveld, Piet L. C. M. van Riel, Loriane Gutermann, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Georg Schett, Kimme L Hyrich, Ulf Müeller-Ladner, Maya H Buch, Iain B. McInnes, Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2020 被引用: 539

  2. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

    著者: Carina Gøtestam Skorpen, Maria Hoeltzenbein, Anǵela Tincani, Rebecca Fischer‐Betz, Élisabeth Éléfant, Christina Chambers, José António Pereira da Silva, Catherine Nelson‐Piercy, Irene Cetin, N. Costedoat‐Chalumeau, Radboud J. E. M. Dolhain, Frauke Förger, Munther A. Khamashta, Guillermo Ruiz‐Irastorza, A. Zink, Jiří Vencovský, Maurizio Cutolo, N. Caeyers, Claudia Zumbühl, Monika Østensen - Annals of the Rheumatic Diseases 2016 被引用: 1,058

  3. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis

    著者: György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C. van der Goes, Alison Kent, Margôt Bakkers, Polina Pchelnikova, Etienne Blaas, Ladislav Šenolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W. G. Jacobs, Rinie Geenen, J. W. J. Bijlsma, A. Zink, Daniel Aletaha, Leonard Schoneveld, Piet L. C. M. van Riel, Sophie Dumas, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Georg Schett, Kimme L Hyrich, Ulf Müeller-Ladner, Maya H Buch, Iain B. McInnes, Désirée van der Heijde, Jacob M. van Laar - Annals of the Rheumatic Diseases 2021 被引用: 276

  4. Dose-related patterns of glucocorticoid-induced side effects

    著者: Dörte Huscher, K. Thiele, Erika Gromnica‐Ihle, Gert Hein, W. Demary, R. Dreher, A. Zink, Frank Buttgereit - Annals of the Rheumatic Diseases 2008 被引用: 582

  5. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    著者: David T. Felson, Josef S Smolen, George A. Wells, Bin Zhang, L. van Tuyl, Julia Funovits, Daniel Aletaha, Cornelia F Allaart, Joan M. Bathon, Stefano Bombardieri, Peter Brooks, Andrew Brown, Marco Matucci‐Cerinic, Hyon K. Choi, Bernard Combe, Maarten de Wit, Maxime Dougados, Paul Emery, Daniel E. Furst, Juan J. Gómez‐Reino, Gillian Hawker, Edward Keystone, Dinesh Khanna, John Kirwan, Tore K Kvien, Robert Landewé, Joachim Listing, Kaleb Michaud, E. Martín‐Mola, Pamela Montie, Theodore Pincus, Pamela Richards, Jeffrey N. Siegel, Lee S. Simon, Tuulikki Sokka, Vibeke Strand, Peter Tugwell, Alan Tyndall, Desirée van der Heijde, Suzanne Verstappen, Barbara White, Frederick Wolfe, A. Zink, Maarten Boers - Annals of the Rheumatic Diseases 2011 被引用: 1,019

  6. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

    著者: Joachim Listing, Kerstin Gerhold, A. Zink - Lara D. Veeken 2012 被引用: 542

  7. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

    著者: Joachim Listing, Jörn Kekow, Bernhard Manger, Gerd‐Rüdiger Burmester, Dagmar Pattloch, A. Zink, Anja Strangfeld - Annals of the Rheumatic Diseases 2013 被引用: 288

  8. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

    著者: Jürgen Braun, J. Brandt, Joachim Listing, A. Zink, Rieke Alten, W. Golder, E Gromnica-lhle, H. Kellner, Andreas Krause, Matthias Schneider, H. Sörensen, H. Zeidler, Wolfgang Thriene, Joachim Sieper - The Lancet 2002 被引用: 1,266

  9. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

    著者: Laure Gossec, Josef S Smolen, Sofía Ramiro, M. De Wit, Maurizio Cutolo, Maxime Dougados, Paul Emery, R. Landewé, Susan Oliver, Daniel Aletaha, Neil Betteridge, Jürgen Braun, Gerd R Burmester, Juan D. Cañete, Nemanja Damjanov, Oliver FitzGerald, Emma Haglund, Philip Helliwell, T. K. Kvien, Rik Lories, Thomas A. Luger, Mara Maccarone, Helena Marzo‐Ortega, Dennis McGonagle, Iain B. McInnes, Ignazio Olivieri, Karel Pavelká, Georg Schett, Joachim Sieper, Filip Van den Bosch, Douglas J. Veale, J. Wollenhaupt, A. Zink, Désirée van der Heijde - Annals of the Rheumatic Diseases 2016 被引用: 913

  10. Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register

    著者: Imke Redeker, Katinka Albrecht, Joern Kekow, Gerd R Burmester, Jürgen Braun, Martin Schäfer, A. Zink, Anja Strangfeld - Annals of the Rheumatic Diseases 2021 被引用: 92

  11. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

    著者: Anja Strangfeld, Maria Eveslage, Matthias Schneider, H. J. Bergerhausen, T. Klopsch, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2011 被引用: 362

  12. Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

    著者: Imke Redeker, Johanna Callhoff, Falk Hoffmann, Hildrun Haibel, Joachim Sieper, A. Zink, Denis Poddubnyy - Lara D. Veeken 2019 被引用: 152

  13. Ankylosing spondylitis: an overview

    著者: Joachim Sieper, Jürgen Braun, Martín Rudwaleit, Annelies Boonen, A. Zink - Annals of the Rheumatic Diseases 2002 被引用: 660

  14. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

    著者: Anja Strangfeld, Franka Hierse, Rolf Rau, Gerd‐Ruediger Burmester, Brigitte Krummel-Lorenz, W. Demary, Joachim Listing, A. Zink - Arthritis Research & Therapy 2010 被引用: 262

  15. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

    著者: Anja Strangfeld, Adrian Richter, Britta Siegmund, P. Herzer, Karin Rockwitz, W. Demary, Martin Aringer, Yvette Meißner, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2016 被引用: 193

  16. EULAR recommendations for a core data set for pregnancy registries in rheumatology

    著者: Yvette Meißner, Rebecca Fischer‐Betz, Laura Andréoli, N. Costedoat‐Chalumeau, Diederik De Cock, Radboud J. E. M. Dolhain, Frauke Förger, Doreen Goll, Anna Moltó, Catherine Nelson‐Piercy, Rebecca Özdemir, Luigi Raio, S. C. Rodriguez-García, Savino Sciascia, Marianne Wallenius, Astrid Zbinden, A. Zink, Anja Strangfeld - Annals of the Rheumatic Diseases 2020 被引用: 83

  17. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative

    著者: Athan Baillet, Laure Gossec, Loreto Carmona, Maarten de Wit, Yvonne van Eijk‐Hustings, Heidi Bertheussen, Kent Alison, Mette Toft, Marios Kouloumas, Ricardo J O Ferreira, Susan Oliver, Andrea Rubbert‐Roth, Sander van Assen, William G Dixon, Axel Finckh, A. Zink, Joel M. Kremer, Tore K Kvien, Michael T. Nurmohamed, Désirée van der Heijde, Maxime Dougados - Annals of the Rheumatic Diseases 2016 被引用: 256

  18. Infections in patients with rheumatoid arthritis treated with biologic agents

    著者: Joachim Listing, Anja Strangfeld, S. Kary, Rolf Rau, U von Hinueber, Maria Stoyanova‐Scholz, Erika Gromnica‐Ihle, Christian Antoni, P. Herzer, Jörn Kekow, Matthias Schneider, A. Zink - Arthritis & Rheumatism 2005 被引用: 687

  19. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

    著者: Louise Mercer, Johan Askling, Pauline Raaschou, William G Dixon, Lene Dreyer, Merete Lund Hetland, Anja Strangfeld, A. Zink, Xavier Mariette, Axel Finckh, Helena Canhão, Florenzo Iannone, Jakub Závada, Jacques Morel, Jacques‐Eric Gottenberg, Kimme L Hyrich, Joachim Listing - Annals of the Rheumatic Diseases 2016 被引用: 188

  20. Prevalence and treatment of hip and knee osteoarthritis in people aged 60 years or older in Germany: an analysis based on health insurance claims data

    著者: Anne Postler, Andres Luque Ramos, Jens Goronzy, Klaus‐Peter Günther, Toni Lange, Jochen Schmitt, A. Zink, Falk Hoffmann - Clinical Interventions in Aging 2018 被引用: 183

  21. Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

    著者: Imke Redeker, Falk Hoffmann, Johanna Callhoff, Hildrun Haibel, Joachim Sieper, A. Zink, Denis Poddubnyy - Annals of the Rheumatic Diseases 2018 被引用: 81

  22. Positioning of total knee arthroplasty with and without navigation support

    著者: M. Sparmann, B. Wolke, H. Czupalla, D. Banzer, A. Zink - Journal of Bone and Joint Surgery - British Volume 2003 被引用: 518

  23. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis

    著者: Johanna Callhoff, Joachim Sieper, Anja Weiß, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2014 被引用: 213

  24. Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

    著者: Joachim Listing, Anja Strangfeld, Jörn Kekow, Matthias Schneider, A Kapelle, Siegfried Wassenberg, A. Zink - Arthritis & Rheumatism 2008 被引用: 195